The interim president and CEO, David D. Stevens, will remain chairman of the Board. Mr. Palmisano most recently served as president and CEO of ev3, a global endovascular device company, where he was able to triple the company's market capitalization during his two-year tenure.
The company's compensation committee of its board of directors has approved a stock option in addition to regular compensation to Mr. Palmisano.
Related Articles on Orthopedic Device Companies:
DJO Global Launches New Technology to Combat Knee Pain
BioMedGPS Launches SmartTRAK Shoulder Recon Module
42 Orthopedic and Spine Devices Receive FDA 510(k) Clearance in August
Wright Medical Group Names Robert Palmisano President and CEOWritten by Laura Miller | September 19, 2011
Wright Medical Group has named Robert J. Palmisano president and CEO, according to a Wright Medical Group news release.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.